The FDA has approved semaglutide for treating MASH, a significant advancement in liver disease management. Semaglutide, ...

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

Madrigal Pharmaceuticals has secured conditional marketing authorization for Rezdiffra, its treatment for a serious liver condition, from regulators in Europe. The biopharmaceutical company said ...

4. Add the eggplant pieces to the pan. Turn them over in the sauce. Cook over medium-low heat for 3 minutes, or until the ...

Uncle Nearest claimed four Golds at the 2025 BTI Tennessee Whiskey Judging, but Costco’s Kirkland bottling shown, offering ...

The Tigers are roaring again. On Monday, they rolled over their closest competitor in the race for a postseason first-round ...

Soup and beer fans are getting a new mash-up this fall. Campbell’s Chunky is partnering with Pabst Blue Ribbon to launch two ...

The string of negative updates from Novo Nordisk and positive news flow from the main competitor Eli Lilly has finally ended ...

In front of a sold-out Richmond Raceway crowd, the NASCAR Cup Series put on a show on Saturday night with tire wear. Austin ...

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...